LANSING, MI – The Michigan Department of Health and Human Services suggests vaccine providers resume use of the Johnson & Johnson vaccine following guidance from federal experts.
The U.S. Centers for Disease Control and the Food and Drug Administration conducted a safety review of the vaccine following an 11-day recommended pause to investigate rare cases of severe blood clotting.
The federal agencies determined Friday, April 23 that use of the Johnson & Johnson vaccine should be resumed in the United States in individuals 18 years and older.
“This brief pause indicates there is a robust safety review process in place for these vaccines,” said the state’s chief medical executive Dr. Joneigh Khaldun in a statement.
Related: Resumed use of Johnson & Johnson’s COVID-19 vaccine recommended by CDC advisory group
Nearly 8 million doses of the Johnson & Johnson vaccine have been administered across the county, and the CDC implemented a pause following reports of six cases of thrombosis with thrombocytopenia syndrome, or TTS.
The rare condition involves severe blood clotting associated with low platelet counts, which requires a different treatment than more common forms of blood clots.
During the pause, the CDC and the FDA investigated the risk of thrombosis. The teams also reached out to health care providers to make them aware of the possible adverse effects and provide guidance on managing and recognizing cases.
In total, 15 cases of TTS have been found, including the original six cases.
All occurred in women between the ages of 18 and 59. Reports indicated symptoms of severe headache, chills, fever, nausea/vomiting, abdominal pain, speech difficulty, loss of consciousness and seizure started between six and 15 days after the vaccination.
Three women died and seven remained hospitalized.
The federal agencies said the vaccine’s “known and potential benefits” outweigh the risks for adults.
“At this time, the available data suggest that the chance of TTS occurring is very low, but the FDA and CDC will remain vigilant in continuing to investigate this risk,” said a news release from the Michigan Department of Health and Human Services.
Michigan has administered 220,082 doses of the Johnson & Johnson vaccine to date. In total, the state reports more than 6.38 million administered doses of the vaccine—including 3.85 million first dose and 2.53 million second dose.
More on MLive:
COVID-19 vaccination required for University of Michigan students living on campus in fall
Grand Rapids airport receives outbreak prevention accreditation
COVID canceled her reception, so this Michigan native wore her wedding dress to get vaccinated
"Review" - Google News
April 24, 2021 at 08:04PM
https://ift.tt/3niUgS7
Michigan to resume use of Johnson & Johnson vaccine following federal review - MLive.com
"Review" - Google News
https://ift.tt/2YqLwiz
https://ift.tt/3c9nRHD
Bagikan Berita Ini
0 Response to "Michigan to resume use of Johnson & Johnson vaccine following federal review - MLive.com"
Post a Comment